BP000093-CYT-149: Recombinant Human 4-1BB Ligand
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by the dose-dependent stimulation of IL-8 production by human PBMC. The ED50 for this effect is 5-10ug/ml corresponding to a Specific Activity of 100,000-200,000 IU/mg.
Purity > 95%, by SDS-PAGE.BP000093-CYT-649: Recombinant Human 4-1BB Ligand, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS-PAGE.BP000094-CYT-137: Recombinant Human 4-1BB Receptor, His Tag
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.BP000094-CYT-463: Recombinant Human 4-1BB Receptor
Source: E. coli-derived.
The activity was determined by the inhibition of 4-1BB ligand mediated stimulation of IL-8 production by human PBMC. Results: 90% inhibition using 1 for both 4-1BB ligand and 4-1BB receptor.
Purity > 98%, by SDS-PAGE and RP-HPLC.